PLATELET ALPHA-2-ADRENERGIC RECEPTOR-BINDING SITES IN MAJOR DEPRESSIVE DISORDER AND BORDERLINE PERSONALITY-DISORDER

被引:13
|
作者
SOUTHWICK, SM
YEHUDA, R
GILLER, EL
PERRY, BD
机构
[1] UNIV CHICAGO, DEPT PSYCHIAT,CHILD & ADOLESCENT PSYCHIAT SECT, BOX 411,5841 S MARYLAND AVE, CHICAGO, IL 60637 USA
[2] UNIV CONNECTICUT, CTR HLTH, UNIV HOSP PROGRAMS, FARMINGTON, CT 06032 USA
[3] VET ADM MED CTR, POSTRAUMAT STRESS DISORDER PROGRAM, W HAVEN, CT 06516 USA
[4] NATL CTR POSTRAUMAT STRESS DISORDER, DIV CLIN NEUROSCI, NEW HAVEN, CT USA
[5] YALE UNIV, SCH MED, PSYCHIAT, NEW HAVEN, CT 06510 USA
[6] UNIV CONNECTICUT, CTR HLTH, PSYCHIAT PSYCHOL, FARMINGTON, CT 06032 USA
[7] VET ADM MED CTR, PSYCHIAT SERV, W HAVEN, CT 06516 USA
[8] UNIV CONNECTICUT, CTR HLTH, PSYCHIAT, FARMINGTON, CT 06032 USA
关键词
!sup]3[!/sup]H-rauwolscine; borderline personality disorder; catecholamines; major depressive disorder; Platelet α[!sub]2[!/sub]-adrenergic receptor binding; radioligand binding studies;
D O I
10.1016/0165-1781(90)90019-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Platelet α2-adrenergic receptor binding sites were measured in a group of patients with major depressive disorder (MDD) (n = 23) and in normal controls (n = 25). When all depressed subjects were compared to controls, there were no differences in either Kd (affinity of the ligand) or total binding site (number/platelet), although a significant change in the ratio of high to low affinity states was observed in the depressed group. When the depressed patients were subdivided into those with and without a co-occuring borderline personality disorder (BPD), the BPD group had significantly fewer α2 high affinity binding sites, while the group with depression alone had significantly more binding sites (both low and high affinity) than the control group. The results support the concept that assessment of comorbid diagnoses may be essential to biological studies of depression. © 1990.
引用
收藏
页码:193 / 203
页数:11
相关论文
共 50 条
  • [31] Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder
    Kahl, KG
    Bens, S
    Ziegler, K
    Rudolf, S
    Dibbelt, L
    Kordon, A
    Schweiger, U
    BIOLOGICAL PSYCHIATRY, 2006, 59 (07) : 667 - 671
  • [32] Association between baseline dissociation levels and stress-induced state dissociation in patients with posttraumatic-stress disorder, borderline personality disorder, and major depressive disorder
    Livia Graumann
    Johannes Bodo Heekerens
    Moritz Duesenberg
    Sophie Metz
    Carsten Spitzer
    Christian Otte
    Stefan Roepke
    Katja Wingenfeld
    Borderline Personality Disorder and Emotion Dysregulation, 10
  • [33] Association between baseline dissociation levels and stress-induced state dissociation in patients with posttraumatic-stress disorder, borderline personality disorder, and major depressive disorder
    Graumann, Livia
    Heekerens, Johannes Bodo
    Duesenberg, Moritz
    Metz, Sophie
    Spitzer, Carsten
    Otte, Christian
    Roepke, Stefan
    Wingenfeld, Katja
    BORDERLINE PERSONALITY DISORDER AND EMOTION DYSREGULATION, 2023, 10 (01)
  • [34] Positron Emission Tomography of Regional Brain Metabolic Responses to a Serotonergic Challenge in Major Depressive Disorder with and without Borderline Personality Disorder
    Maria A Oquendo
    Aleksandra Krunic
    Ramin V Parsey
    Matthew Milak
    Kevin M Malone
    Amy Anderson
    Ronald L van Heertum
    J John Mann
    Neuropsychopharmacology, 2005, 30 : 1163 - 1172
  • [35] Mother-infant interactions in women with borderline personality disorder, major depressive disorder, their co-occurrence, and healthy controls
    White, Henry
    Flanagan, T. John
    Martin, Ariel
    Silvermann, David
    JOURNAL OF REPRODUCTIVE AND INFANT PSYCHOLOGY, 2011, 29 (03) : 223 - 235
  • [36] Functional Connectivity Abnormalities in Major Depressive Disorder With and Without Co-Morbid Borderline Personality Disorder and Implications for Treatment With TMS
    Dubin, Marc
    Ilieva, Irena
    Cochran, Ashley
    Liston, Conor
    Gunning, Faith
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S109 - S110
  • [37] Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder
    Oquendo, MA
    Krunic, A
    Parsey, RV
    Milak, M
    Malone, KM
    Anderson, A
    van Heertum, RL
    Mann, JJ
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (06) : 1163 - 1172
  • [38] THE RELATIONSHIP OF PLATELET 5-HT(2) RECEPTOR INDEXES TO MAJOR DEPRESSIVE DISORDER, PERSONALITY-TRAITS, AND SUICIDAL-BEHAVIOR
    MCBRIDE, PA
    BROWN, RP
    DEMEO, M
    KEILP, J
    MIECZKOWSKI, T
    MANN, JJ
    BIOLOGICAL PSYCHIATRY, 1994, 35 (05) : 295 - 308
  • [39] Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review
    Roepke, Stefan
    Danker-Hopfe, Heidi
    Repantis, Dimitris
    Behnia, Behnoush
    Bernard, Florian
    Hansen, Marie-Luise
    Otte, Christian
    PHARMACOPSYCHIATRY, 2017, 50 (01) : 26 - 31
  • [40] Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder
    Kin, NMKNY
    Paris, J
    Schwartz, G
    Zweig-Frank, H
    Steiger, H
    Nair, NPV
    PSYCHOPHARMACOLOGY, 2005, 182 (03) : 447 - 451